Delivery Order SPE2DB22D1200-SPE2DB25FN0FE
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,078.77 and runs through February 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,823.61 firm fixed-price delivery order is for the supply of 4,568,186,025 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a completion date of May 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S. The $1,805.10 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Naloxone HCL 4 mg nasal spray to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $8,554.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of May 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
This federal contract award is for the delivery of 4,559,880,629 units of Naloxone HCL 4 mg Nasal Spray to the Defense Logistics Agency (DLA) under Delivery Order SPE2DB23FN50R. The $12,160.51 firm fixed-price contract was awarded on February 8, 2023 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a completion date of February 9, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naloxone HCL 4 mg nasal spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,197.16 and an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY, with a ceiling value of $2,241.01 and a completion date of June 10, 2025. This is a firm fixed price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,560,315,275 units of Naloxone HCL 4 mg Nasal Spray. The $2,556.39 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 21, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,578.14 firm fixed-price delivery order covers the supply of 4,557,905,370 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a completion date of July 27, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...